Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 17


Concurrent access to nicotine and sucrose in rats.

Panlilio LV, Hogarth L, Shoaib M.

Psychopharmacology (Berl). 2015 Apr;232(8):1451-60. doi: 10.1007/s00213-014-3787-8. Epub 2014 Nov 1.


NIH electronic cigarette workshop: developing a research agenda.

Walton KM, Abrams DB, Bailey WC, Clark D, Connolly GN, Djordjevic MV, Eissenberg TE, Fiore MC, Goniewicz ML, Haverkos L, Hecht SS, Henningfield JE, Hughes JR, Oncken CA, Postow L, Rose JE, Wanke KL, Yang L, Hatsukami DK.

Nicotine Tob Res. 2015 Feb;17(2):259-69. doi: 10.1093/ntr/ntu214. Epub 2014 Oct 21.


Reducing the nicotine content to make cigarettes less addictive.

Benowitz NL, Henningfield JE.

Tob Control. 2013 May;22 Suppl 1:i14-7. doi: 10.1136/tobaccocontrol-2012-050860. Review.


Subjective responses to oral tobacco products: scale validation.

Hatsukami DK, Zhang Y, O'Connor RJ, Severson HH.

Nicotine Tob Res. 2013 Jul;15(7):1259-64. doi: 10.1093/ntr/nts265. Epub 2012 Dec 13.


A rat model of cigarette smoke abuse liability.

Ypsilantis P, Politou M, Anagnostopoulos C, Kortsaris A, Simopoulos C.

Comp Med. 2012 Oct;62(5):395-9.


Nicotine reduction: strategic research plan.

Hatsukami DK, Benowitz NL, Donny E, Henningfield J, Zeller M.

Nicotine Tob Res. 2013 Jun;15(6):1003-13. doi: 10.1093/ntr/nts214. Epub 2012 Oct 25. Review.


What would menthol smokers do if menthol in cigarettes were banned? Behavioral intentions and simulated demand.

O'Connor RJ, Bansal-Travers M, Carter LP, Cummings KM.

Addiction. 2012 Jul;107(7):1330-8. doi: 10.1111/j.1360-0443.2012.03822.x. Epub 2012 Apr 4.


Clinical laboratory assessment of the abuse liability of an electronic cigarette.

Vansickel AR, Weaver MF, Eissenberg T.

Addiction. 2012 Aug;107(8):1493-500. doi: 10.1111/j.1360-0443.2012.03791.x. Epub 2012 May 8.


Cigarette smoke, bacteria, mold, microbial toxins, and chronic lung inflammation.

Pauly JL, Paszkiewicz G.

J Oncol. 2011;2011:819129. doi: 10.1155/2011/819129. Epub 2011 Jul 9.


US attitudes about banning menthol in cigarettes: results from a nationally representative survey.

Winickoff JP, McMillen RC, Vallone DM, Pearson JL, Tanski SE, Dempsey JH, Cheryl Healton, Klein JD, David Abrams.

Am J Public Health. 2011 Jul;101(7):1234-6. doi: 10.2105/AJPH.2011.300146. Epub 2011 May 12.


Tobacco and nicotine product testing.

Hatsukami DK, Biener L, Leischow SJ, Zeller MR.

Nicotine Tob Res. 2012 Jan;14(1):7-17. doi: 10.1093/ntr/ntr027. Epub 2011 Apr 2. Review.


Electronic nicotine delivery systems: a research agenda.

Etter JF, Bullen C, Flouris AD, Laugesen M, Eissenberg T.

Tob Control. 2011 May;20(3):243-8. doi: 10.1136/tc.2010.042168. Epub 2011 Mar 17.


Conference on abuse liability and appeal of tobacco products: conclusions and recommendations.

Henningfield JE, Hatsukami DK, Zeller M, Peters E.

Drug Alcohol Depend. 2011 Jul 1;116(1-3):1-7. doi: 10.1016/j.drugalcdep.2010.12.009. Epub 2011 Mar 3.


Postmarketing surveillance for "modified-risk" tobacco products.

O'Connor RJ.

Nicotine Tob Res. 2012 Jan;14(1):29-42. doi: 10.1093/ntr/ntq243. Epub 2011 Jan 20. Review.


Waterpipe tobacco smoking and cigarette smoking: a direct comparison of toxicant exposure and subjective effects.

Cobb CO, Shihadeh A, Weaver MF, Eissenberg T.

Nicotine Tob Res. 2011 Feb;13(2):78-87. doi: 10.1093/ntr/ntq212. Epub 2010 Dec 2.


A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects.

Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE.

Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1945-53. doi: 10.1158/1055-9965.EPI-10-0288. Epub 2010 Jul 20.


Measures for assessing subjective effects of potential reduced-exposure products.

Hanson K, O'Connor R, Hatsukami D.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3209-24. doi: 10.1158/1055-9965.EPI-09-0971. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk